Gongdong Medical released its 2024 annual performance, with a net profit attributable to the parent company of 172 million yuan, a year-on-year increase of 57.28%
I'm LongbridgeAI, I can summarize articles.Gongdong Medical released its 2024 annual report, with revenue of 1.115 billion yuan, a year-on-year increase of 14.37%; net profit attributable to the parent company of 172 million yuan, a year-on-year increase of 57.28%; net profit excluding non-recurring items of 168 million yuan, a year-on-year increase of 56.18%; basic earnings per share of 1.09 yuan. The company plans to distribute a cash dividend of 4.00 yuan for every 10 shares and to increase its capital by transferring 4 shares for every 10 shares from the statutory surplus reserve
According to the Zhitong Finance APP, Gongdong Medical (605369.SH) disclosed its annual report for 2024. During the reporting period, the company achieved revenue of 1.115 billion yuan, a year-on-year increase of 14.37%; net profit attributable to the parent company was 172 million yuan, a year-on-year increase of 57.28%; net profit excluding non-recurring gains and losses was 168 million yuan, a year-on-year increase of 56.18%; basic earnings per share were 1.09 yuan.
The company plans to distribute a cash dividend of 4.00 yuan (tax included) for every 10 shares to all shareholders and plans to increase capital by transferring 4 shares for every 10 shares to all shareholders using the statutory surplus reserve